The new-look device, still under development, is designed to be worn for weeks at a time. 

A team of Mayo Clinic specialists led the analysis, sharing their findings in Nature Medicine.

“Once the study begins, it will likely be one of the largest heart pacing clinical trials happening in the world over the next few years," one specialist said. 

The application, called Echoes, was designed with help from the British Heart Foundation and Evelina Children’s Heart Organization. It uses an iPhone's built-in microphone to capture recordings of the user's heart. 

Could wearables help AFib patients take fewer blood-thinning medications and reduce their risk of stroke? The team behind a new seven-year analysis hopes to find out. 

The FDA granted the first pediatric indication for an implantable cardiac monitor. The Linq II can be used in pediatric patients over the age of 2 for up to 4.5 years of long-term, continuous monitoring. 

Though removal of the affected CIED is typically the smartest treatment option—and one supported by specialty groups all over the world—a majority of patients keep living with the device, often resulting in hospitalization or even death.

The recall is related to short circuit protection (SCP) alerts that were causing the devices to send reduced-energy electric shocks. There have been 27 customer complaints about the issue so far.